Zynerba Pharmaceuticals Presents Data on Zygel at the 55th Gatlinburg Conference

12.04.2023 - Zygel continued to be well-tolerated with long-term administration and maintained clinically meaningful improvements in children and adolescents with Fragile X syndrome Zygel achieved statistically significant and clinically meaningful improvements ... Seite 1

Related Keywords

Armando Anido ,Nasdaq ,Zynerba Pharmaceuticals Inc ,Gatlinburg Conference ,Kansas City ,Chief Executive Officer ,Sustained Efficacy ,Transdermal Gel ,Fragilex Syndrome ,Open Label Tolerability ,Efficacy Study ,Pediatric Anxiety Rating Scale ,Mood Scale ,Aberrant Behavior Checklist ,